Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.29 0.22(2.43%) Jul 23, 4:00PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
HALOPVT1PVT2PVT3Industry
Market Cap:1.10BN/AN/AN/AN/A
Employees:170N/AN/AN/AN/A
Qtrly Rev Growth (yoy):0.01N/AN/AN/AN/A
Revenue (ttm): 54.93MN/AN/AN/AN/A
Gross Margin (ttm):-0.95N/AN/AN/AN/A
EBITDA (ttm):-85.83MN/AN/AN/AN/A
Operating Margin (ttm): -1.59N/AN/AN/AN/A
Net Income (ttm):-90.74MN/AN/AN/AN/A
EPS (ttm):-0.79N/AN/AN/AN/A
P/E (ttm):N/AN/AN/AN/AN/A
PEG (5 yr expected):N/AN/AN/AN/AN/A
P/S (ttm):19.64N/AN/AN/AN/A
 
Pvt1 = CooperSurgical, Inc. (privately held)
Pvt2 = Irvine Scientific (privately held)
Pvt3 = ISTA Pharmaceuticals, Inc. (privately held)

 
News on Direct Competitors 
No Direct Competitor Comparision

Currency in USD.